Original article
The role of the methacholine challenge in children with chronic cough

https://doi.org/10.1016/0091-6749(87)90150-3Get rights and content

Abstract

Thirty-nine male and 35 female subjects, aged 6 to 20 years, with chronic cough were studied with spirometry and standard methacholine (MCH) challenge. The duration of their cough before the MCH challenge ranged from 2 months to 13 years. Their FEV1 ranged 62% to 132% predicted. Thirty-six (49%) patients had a positive MCH challenge. The MCH concentration inhaled to decrease the FEV1 by 20% ranged from 0.55 to 25 mg/ml. Follow-up data (mean 14 months) were available on all 74 patients. Fifty-four patients received asthma medications, and 93% improved in mean 3.6 weeks. At the end of the follow-up, 22 (30%) were asymptomatic, 39 (53%) were improved, and 13 patients (17%) were symptomatic. We were unable to predict bronchial hyperreactivity in this population on the basis of duration of the cough, personal or family history of allergies, or baseline spirometry. Thus, MCH challenge is helpful in evaluating children with chronic cough and in guiding therapy. Follow-up of children with chronic cough is important. Eleven percent of this study population progressed to develop bronchial asthma. Forty percent of these patients, initially doing well, were asymptomatic at the end of the follow-up period.

References (27)

  • RS Irwin et al.

    Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy

    Am Rev Respir Dis

    (1981)
  • RH Poe et al.

    Chronic cough: bronchoscopy or pulmonary function testing

    Am Rev Respir Dis

    (1980)
  • RF Sacha et al.

    Chronic cough sinusitis and hyperreactive airways in children: an often overlooked association

    Ann Allergy

    (1985)
  • Cited by (45)

    • Managing Chronic Cough as a Symptom in Children and Management Algorithms: CHEST Guideline and Expert Panel Report

      2020, Chest
      Citation Excerpt :

      Further, AHR in children may occur temporarily post-infections50 and with allergic rhinitis. Also, demonstration of AHR in a child with isolated cough may not be helpful in predicting the later development of asthma57 or the response to asthma medications.46 In the single RCT that examined the utility of AHR and response to inhaled salbutamol and inhaled corticosteroids (ICS) for children with isolated recurrent cough (median cough was 8 weeks),46 AHR presence could not predict the efficacy of inhaled salbutamol and corticosteroids (beclomethasone 400 μg/day) for cough frequency or cough sensitivity.

    • Psychiatric Aspects of Respiratory Symptoms

      2008, Pediatric Respiratory Medicine
    • Cough and asthma

      2006, Paediatric Respiratory Reviews
    • Guidelines for evaluating chronic cough in pediatrics: ACCP evidence-based clinical practice guidelines

      2006, Chest
      Citation Excerpt :

      Tests for airway hyperresponsiveness (AHR) are not used in routine practice in most pediatric pulmonary laboratories to diagnose asthma.71 The presence of AHR does not mean that asthma is present in children,72 and the demonstration of AHR in a child with isolated cough is unlikely to be helpful in predicting the later development of asthma73 or the response to asthma medications.74 Older studies75–78 have stated that the presence of AHR in children with cough is said to be representative of asthma.

    View all citing articles on Scopus
    View full text